Risk of breakthrough SARS-CoV-2 infection and clinical outcomes among patients with type 2 diabetes

被引：0
|
作者：
Bea, Sungho [1 ]
Choi, Ahhyung [2 ]
Kim, Jae Hyeon [3 ]
Cho, Young Min [4 ]
Choi, Won Suk [5 ]
Jung, Jaehun [6 ]
Shin, Ju-Young [1 ]
机构：
[1] Sungkyunkwan Univ, Sch Pharm, Suwon, South Korea
[2] SKKU, Sch Pharm, Suwon, South Korea
[3] Sungkyunkwan Univ, Div Endocrinol & Metab, Dept Med, Samsung Med Ctr,Sch Med, Seoul, South Korea
[4] Seoul Natl Univ, Dept Internal Med, Coll Med, Seoul, South Korea
[5] Korea Univ, Ansan Hosp, Div Infect Dis, Dept Internal Med,Coll Med, Ansan, South Korea
[6] Gachon Univ, Dept Prevent Med, Coll Med, Incheon, South Korea
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2023年 / 32卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
188
引用
收藏
页码：80 / 80
页数：1
相关论文
共 50 条
  • [21] The Risk of SARS-CoV-2 Infection Among Healthcare Workers
    Madran, Bahar
    Keske, Siran
    Besli, Yesim
    Bozkurt, Ismail
    Ergonul, Onder
    INFECTIOUS DISEASES AND CLINICAL MICROBIOLOGY, 2020, 2 (02): : 54 - 60
  • [22] Clinical Frailty Scale for risk stratification in patients with SARS-CoV-2 infection
    Labenz, Christian
    Kremer, Wolfgang M.
    Schattenberg, Joern M.
    Woerns, Marcus-Alexander
    Toenges, Gerrit
    Weinmann, Arndt
    Galle, Peter R.
    Sprinzl, Martin F.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2020, 68 (06) : 1199 - 1202
  • [23] SARS-CoV-2 infection in hospitalized children with type 1 and type 2 diabetes
    Trieu, Connie
    Sunil, Bhuvana
    Ashraf, Ambika P.
    Cooper, Joshua
    Yarbrough, April
    Pinninti, Swetha
    Boppana, Suresh
    JOURNAL OF CLINICAL AND TRANSLATIONAL ENDOCRINOLOGY, 2021, 26
  • [24] Renin-Angiotensin System Overactivation in Type 2 Diabetes: A Risk for SARS-CoV-2 Infection?
    Moin, Abu Saleh Md
    Al-Qaissi, Ahmed
    Sathyapalan, Thozhukat
    Atkin, Stephen L.
    Butler, Alexandra E.
    DIABETES CARE, 2020, 43 (10) : E131 - E133
  • [25] Characterization and Outcomes of SARS-CoV-2 Infection in Patients with Sarcoidosis
    Brito-Zeron, P.
    Gracia-Tello, B.
    Robles, A.
    Alguacil, A.
    Bonet, M.
    De-Escalante, B.
    Noblejas-Mosso, A.
    Gomez-de-la-Torre, R.
    Akasbi, M.
    Perez-de-Lis, M.
    Perez-Alvarez, R.
    Ramos-Casals, M.
    VIRUSES-BASEL, 2021, 13 (06):
  • [26] Outcomes and implications of diarrhea in patients with SARS-CoV-2 infection
    Shang, Haitao
    Bai, Tao
    Chen, Yuhua
    Huang, Chao
    Zhang, Shengyan
    Yang, Pengcheng
    Zhang, Lei
    Hou, Xiaohua
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2020, 55 (09) : 1049 - 1056
  • [27] Glucose control during breakthrough SARS-CoV-2 infections in vaccinated patients with type 1 diabetes
    Longo, Miriam
    Scappaticcio, Lorenzo
    Signoriello, Simona
    Caruso, Paola
    Maio, Antonietta
    Botta, Graziella
    Arena, Stefania
    Cirillo, Paolo
    Petrizzo, Michela
    Bellastella, Giuseppe
    Maiorino, Maria Ida
    Chiodini, Paolo
    Esposito, Katherine
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2024, 207
  • [28] Risk of appendicitis after SARS-CoV-2 infection and SARS-CoV-2 vaccination
    Ljung, Rickard
    Pihlstrom, Nicklas
    Sundstrom, Anders
    BRITISH JOURNAL OF SURGERY, 2022, 109 (08) : 775 - 776
  • [29] What should define a SARS-CoV-2 "breakthrough" infection?
    Schieffelin, John S.
    Norton, Elizabeth B.
    Kolls, Jay K.
    JOURNAL OF CLINICAL INVESTIGATION, 2021, 131 (12):
  • [30] Diabetes after SARS-CoV-2 infection
    Al-Aly, Ziyad
    LANCET DIABETES & ENDOCRINOLOGY, 2023, 11 (01): : 11 - 13
12345